scispace - formally typeset
M

Mark Dybul

Researcher at National Institutes of Health

Publications -  14
Citations -  3558

Mark Dybul is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 13, co-authored 14 publications receiving 3469 citations.

Papers
More filters
Journal ArticleDOI

HIV preferentially infects HIV-specific CD4 + T cells

TL;DR: The findings show that HIV-specific CD4+ T cells are preferentially infected by HIV in vivo, which provides a potential mechanism to explain the loss of HIV- specific CD4- T-cell responses, and consequently theloss of immunological control of HIV replication.
Journal ArticleDOI

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: The Panel on Clinical Practices for Treatment of HIV

TL;DR: This report provides pathogenesis-based rationale for therapeutic strategies as well as guidelines for implementing these strategies and recommends that, when possible, the treatment of HIV-infected patients should be directed by a clinician who has extensive experience in the care of these patients.
Journal ArticleDOI

Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor

TL;DR: It is shown that recombinant envelope proteins from macrophage-tropic HIV and SIV induce a signal through CCR5 on CD4+ T cells and that envelope-mediated signal transduction through C CR5 induces chemotaxis of T cells.
Journal ArticleDOI

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

TL;DR: It is demonstrated that altered expression of genes associated with IFN stimulation and terminal differentiation in B cells of HIV-viremic patients lead to an increased propensity to cell death, which may have substantial deleterious effects on B cell responsiveness to antigenic stimulation.